AccuStem Sciences Limited
ACMSY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,487 | $1,475 | $1,487 | $1,600 |
| - Cash | $5 | $0 | $734 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,482 | $1,475 | $753 | $1,600 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,505 | -$2,051 | -$3,746 | -$671 |
| % Margin | – | – | – | – |
| Net Income | -$1,505 | -$2,051 | -$3,746 | -$671 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.18 | -0.34 | -0.067 |
| % Growth | 27.8% | 47.1% | -406.7% | – |
| Operating Cash Flow | -$664 | – | -$1,806 | – |
| Capital Expenditures | $0 | – | $0 | – |
| Free Cash Flow | -$664 | – | -$1,806 | – |